<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599811432535</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599811432535</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Systematic Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>No Evidence for the Diagnostic Value of Borrelia Serology in Patients with Sudden Hearing Loss</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Bakker</surname><given-names>Renée</given-names></name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff1-0194599811432535">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Aarts</surname><given-names>Mark C. J.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599811432535">1</xref>
<xref ref-type="aff" rid="aff2-0194599811432535">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>van der Heijden</surname><given-names>Geert J. M. G.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599811432535">1</xref>
<xref ref-type="aff" rid="aff3-0194599811432535">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rovers</surname><given-names>Maroeska M.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599811432535">1</xref>
<xref ref-type="aff" rid="aff3-0194599811432535">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599811432535"><label>1</label>University Medical Centre, Utrecht, The Netherlands</aff>
<aff id="aff2-0194599811432535"><label>2</label>Rudolf Magnus Institute of Neuroscience, Utrecht, The Netherlands</aff>
<aff id="aff3-0194599811432535"><label>3</label>Julius Centre for Health Sciences and Primary Care, Utrecht, The Netherlands</aff>
<author-notes>
<corresp id="corresp1-0194599811432535">Renée Bakker, Department of Otolaryngology, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands Email: <email>ENT-Research@umcutrecht.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>146</volume>
<issue>4</issue>
<fpage>539</fpage>
<lpage>543</lpage>
<history>
<date date-type="received">
<day>8</day>
<month>10</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>11</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<p>In this evidence-based case report, we address the following clinical question: What is the predictive value of serological testing for <italic>Borrelia</italic> for diagnosing neuroborreliosis in patients with sudden sensorineural hearing loss? We searched for relevant articles in PubMed, Embase, and Web of Science. We retrieved 49 unique publications and screened the title and abstract of these articles for relevance. We included 2 of 12 studies initially considered relevant to answer our question. These 2 studies reported a seroprevalence of antibodies against <italic>Borrelia</italic> of 16% in patients with sudden sensorineural hearing loss (SHL) as compared with 13.5% in the general population, but in neither patients with definite neuroborreliosis were they found. To date, there is no evidence regarding the added value of routine diagnostic serologic testing for <italic>Borrelia</italic> in diagnosing neuroborreliosis in patients with sudden SHL. Neuroborreliosis seems to be a rare cause of sudden SHL, and routine screening of patients for borrelia antibodies in serum should therefore not be recommended.</p>
</abstract>
<kwd-group>
<kwd>sudden sensorineural hearing loss</kwd>
<kwd>borrelia</kwd>
<kwd>serology</kwd>
<kwd>neuroborreliosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0194599811432535">
<title>Clinical Case</title>
<p>Two days ago, a 47-year-old woman woke up with hearing loss and tinnitus in her left ear. She is healthy and reports no incident preceding her complaints. On examination, her right ear is normal, while basic audiometry confirms left-sided sudden sensorineural hearing loss (SHL). In line with the guidelines for SHL of the Dutch association of ENT surgeons,<sup><xref ref-type="bibr" rid="bibr1-0194599811432535">1</xref></sup> you decide to prescribe her a short course of high-dose oral corticosteroid therapy. In addition, you consider ordering tests for further evaluation of the presence of treatable or dangerous conditions underlying her SHL, such as magnetic resonance imaging and a number of blood tests. While the Dutch ENT guidelines<sup><xref ref-type="bibr" rid="bibr1-0194599811432535">1</xref></sup> recommend diagnostic testing for <italic>Borrelia</italic> in patients with sudden SHL, the Dutch guideline on Lyme disease suggests that when a patient with sudden SHL has not been bitten by a tick, the presence of <italic>Borrelia</italic> is unlikely.<sup><xref ref-type="bibr" rid="bibr2-0194599811432535">2</xref></sup></p>
<p>In the literature, sudden SHL has been associated with <italic>Borrelia</italic> infection.<sup><xref ref-type="bibr" rid="bibr3-0194599811432535">3</xref></sup> This tick-borne spirochete has been shown to cause Lyme disease, for which treatment with antibiotics is indicated. As the European species of the <italic>Borrelia</italic> spirochete is more strongly associated with neurological symptoms than the predominant species in the United States,<sup><xref ref-type="bibr" rid="bibr4-0194599811432535">4</xref></sup> testing for <italic>Borrelia burgdorferi</italic> in patients with sudden SHL has not been considered during the development of the US guideline on sudden SHL, which will be published in 2012 (R. M. Rosenfeld, personal communication).</p>
<p>While the patient does not remember a tick bite, you consider serological testing to rule out the presence of <italic>Borrelia</italic>. But before you settle on ordering such a test, you decide to look for the evidence on the predictive value of serological testing for diagnosing neuroborreliosis in patients sudden SHL.</p>
</sec>
<sec id="section2-0194599811432535">
<title>Searching for Evidence</title>
<p>We formulated the following clinical question: what is the predictive value of serological testing for <italic>Borrelia</italic> in detecting or ruling out neuroborreliosis in patients with sudden SHL?</p>
<p>We designed a search filter using relevant synonyms for the domain, which is patients with SHL, and the determinant, which is <italic>Borrelia</italic> serology (<xref ref-type="table" rid="table1-0194599811432535"><bold>Table 1</bold></xref>). We retrieved relevant publications in Embase, PubMed, and Web of Science using search terms in the title and abstract fields. A related articles search in PubMed and cross-reference checking was used to retrieve relevant missed articles and identify additional useful search terms. A total of 49 unique records were retrieved (<xref ref-type="fig" rid="fig1-0194599811432535"><bold>Figure 1</bold></xref>). All titles and abstracts were screened by R.B. and M.C.J.A. Studies were excluded if they were reviews, animal studies, or case reports; described only children; or were not written in English, Dutch, German, or French (<xref ref-type="fig" rid="fig1-0194599811432535"><bold>Figure 1</bold></xref>). Studies were selected when the following inclusion criteria were met: patients suffering from sudden SHL and serological testing for <italic>Borrelia</italic> with enzyme-linked immunosorbent assay (ELISA) or Western blot, using cerebrospinal fluid (CSF) as reference test for the presence of neuroborreliosis. The criteria for relevance of the serologic tests and proof of neuroborreliosis in CSF were based on the European guidelines on Lyme disease.<sup><xref ref-type="bibr" rid="bibr5-0194599811432535">5</xref></sup> These guidelines state 3 criteria for diagnosing neuroborreliosis: (1) neurological symptoms suggestive of Lyme neuroborreliosis without other obvious reasons, (2) CSF pleiocytosis, and (3) intrathecal production of antibodies against <italic>Borrelia</italic> (which can be determined with an index of antibody titers in serum and CSF). When all 3 criteria are fulfilled, a patient is diagnosed with definite neuroborreliosis, and when 2 criteria are fulfilled, a patient is diagnosed with possible neuroborreliosis.</p>
<table-wrap id="table1-0194599811432535" position="float">
<label>Table 1.</label>
<caption>
<p>Search Strategy<sup><xref ref-type="table-fn" rid="table-fn1-0194599811432535">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table1-0194599811432535" xlink:href="10.1177_0194599811432535-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Database</th>
<th align="center">Search</th>
<th align="center">Hits</th>
</tr>
</thead>
<tbody>
<tr>
<td>PubMed (MEDLINE)</td>
<td>deaf OR deafness OR “hearing loss” OR ((loss OR decline) AND (hear OR hearing OR auditory)) AND<break/>borrelia OR Lyme OR burgdorferi OR borreliosis OR neuroborreliosis OR spirochete OR spirochaete AND<break/>serolog* OR serum OR sera OR blood OR plasma OR antibody OR antibodies OR immunoglobulin OR IgG OR IgM OR ELISA OR EIA OR immunosorbent OR immunofluorescence OR immunoblot OR immunoassay OR screening OR screen OR diagnostic</td>
<td>33</td>
</tr>
<tr>
<td>EMBASE</td>
<td>See PubMed</td>
<td>43</td>
</tr>
<tr>
<td>Web of Science</td>
<td>See PubMed</td>
<td>27</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599811432535">
<label>a</label>
<p>Search terms were used in title and abstract fields only.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig1-0194599811432535" position="float">
<label>Figure 1.</label>
<caption>
<p>Flow chart showing retrieval results and exclusion criteria.</p>
</caption>
<graphic xlink:href="10.1177_0194599811432535-fig1.tif"/>
</fig>
</sec>
<sec id="section3-0194599811432535" sec-type="results">
<title>Results</title>
<p>A total of 49 unique records were retrieved, of which 12 articles were considered potentially relevant after screening titles and abstracts (<xref ref-type="fig" rid="fig1-0194599811432535"><bold>Figure 1</bold></xref>).<sup><xref ref-type="bibr" rid="bibr6-0194599811432535">6</xref>-<xref ref-type="bibr" rid="bibr17-0194599811432535">17</xref></sup> After applying the selection criteria to their full text, 6 articles were eligible for risk-of-bias assessment (<xref ref-type="table" rid="table2-0194599811432535"><bold>Table 2</bold></xref>).</p>
<table-wrap id="table2-0194599811432535" position="float">
<label>Table 2.</label>
<caption>
<p>Criteria for Critical Appraisal of Relevance, Applied on Full Text of Studies Considered Eligible after Screening of Title and Abstract</p>
</caption>
<graphic alternate-form-of="table2-0194599811432535" xlink:href="10.1177_0194599811432535-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="center" colspan="3">Relevance<sup><xref ref-type="table-fn" rid="table-fn2-0194599811432535">a</xref></sup></th>
</tr>
<tr>
<th align="left">First Author (Year)</th>
<th align="center">n</th>
<th align="center">Domain</th>
<th align="center">Determinant</th>
<th align="center">Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lorenzi (2003)<sup><xref ref-type="bibr" rid="bibr6-0194599811432535">6</xref></sup></td>
<td>47</td>
<td>+</td>
<td>+</td>
<td>–</td>
</tr>
<tr>
<td>Walther (2003)<sup><xref ref-type="bibr" rid="bibr7-0194599811432535">7</xref></sup></td>
<td>344</td>
<td>+</td>
<td>+</td>
<td>–</td>
</tr>
<tr>
<td>Gagnebin (2002)<sup><xref ref-type="bibr" rid="bibr8-0194599811432535">8</xref></sup></td>
<td>106</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td>Finizia (2001)<sup><xref ref-type="bibr" rid="bibr9-0194599811432535">9</xref></sup></td>
<td>19</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td>Gagnebin (2000)<sup><xref ref-type="bibr" rid="bibr10-0194599811432535">10</xref></sup></td>
<td>102</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td>Hydén (2000)<sup><xref ref-type="bibr" rid="bibr11-0194599811432535">11</xref></sup></td>
<td>62</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td>Peltomaa (2000)<sup><xref ref-type="bibr" rid="bibr12-0194599811432535">12</xref></sup></td>
<td>230</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td>Hydén (1995)<sup><xref ref-type="bibr" rid="bibr13-0194599811432535">13</xref></sup></td>
<td>21</td>
<td>+</td>
<td>+</td>
<td>+</td>
</tr>
<tr>
<td>Richardson (1994)<sup><xref ref-type="bibr" rid="bibr14-0194599811432535">14</xref></sup></td>
<td>100</td>
<td>+/–</td>
<td>+</td>
<td>–</td>
</tr>
<tr>
<td>Riechelmann (1990)<sup><xref ref-type="bibr" rid="bibr15-0194599811432535">15</xref></sup></td>
<td>72</td>
<td>+/−</td>
<td>+</td>
<td>–</td>
</tr>
<tr>
<td>Wissen-Siegert (1990)<sup><xref ref-type="bibr" rid="bibr16-0194599811432535">16</xref></sup></td>
<td>118</td>
<td>+</td>
<td>+</td>
<td>–</td>
</tr>
<tr>
<td>Hanner (1989)<sup><xref ref-type="bibr" rid="bibr17-0194599811432535">17</xref></sup></td>
<td>98</td>
<td>+/−</td>
<td>–</td>
<td>–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0194599811432535">
<label>a</label>
<p>All studies are prospective cohort studies. Domain: patients with sudden sensorineural hearing loss (+: the included patients have sudden sensorineural hearing loss (sudden SHL); –: the onset of SHL is unclear or the results from patients with sudden SHL are not reported separately); Determinant: antibodies against <italic>Borrelia</italic> measured in serum (+: antibodies were measured using enzyme-linked immunosorbent assay [ELISA] and/or Western blot; –:antibodies were detected with other methods or the detection method is not specified); Outcome: neuroborreliosis diagnosed by assessment of intrathecal antibody production (+: cerebrospinal fluid [CSF] was examined using ELISA antibody index or Western blot and measurement of inflammatory parameters; –:CSF was not examined).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>For the 2 studies that were considered valid, the data could be extracted for answering our clinical question (<xref ref-type="table" rid="table3-0194599811432535"><bold>Table 3</bold></xref>). Both of these 2 remaining studies were performed in large hospitals in the south of Sweden. They tested sera for <italic>Borrelia</italic>-directed antibodies with commercial ELISA kits from the same manufacturer, while all CSF samples were tested for protein content, cell count, and <italic>Borrelia</italic>-directed antibodies.</p>
<table-wrap id="table3-0194599811432535" position="float">
<label>Table 3.</label>
<caption>
<p>Criteria for Critical Appraisal of Validity, Applied to Studies Considered Relevant for Answering the Research Question</p>
</caption>
<graphic alternate-form-of="table3-0194599811432535" xlink:href="10.1177_0194599811432535-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="center" colspan="3">Validity<sup><xref ref-type="table-fn" rid="table-fn3-0194599811432535">a</xref></sup></th>
</tr>
<tr>
<th align="left">First Author (Year)</th>
<th align="center">n</th>
<th align="center">Standardization</th>
<th align="center">Selection Bias</th>
<th align="center">Complete Data</th>
</tr>
</thead>
<tbody>
<tr>
<td>Finizia (2001)<sup><xref ref-type="bibr" rid="bibr9-0194599811432535">9</xref></sup></td>
<td>19</td>
<td>+</td>
<td>+</td>
<td align="center">+</td>
</tr>
<tr>
<td>Hydén (2000)<sup><xref ref-type="bibr" rid="bibr11-0194599811432535">11</xref></sup></td>
<td>62</td>
<td>+</td>
<td>+</td>
<td align="center">+</td>
</tr>
<tr>
<td>Gagnebin (2002)<sup><xref ref-type="bibr" rid="bibr8-0194599811432535">8</xref></sup></td>
<td>106</td>
<td>+/–</td>
<td>–</td>
<td align="center">–</td>
</tr>
<tr>
<td>Gagnebin (2000)<sup><xref ref-type="bibr" rid="bibr10-0194599811432535">10</xref></sup></td>
<td>102</td>
<td>+/–</td>
<td>–</td>
<td>Same cohort</td>
</tr>
<tr>
<td>Peltomaa (2000)<sup><xref ref-type="bibr" rid="bibr12-0194599811432535">12</xref></sup></td>
<td>230</td>
<td>+/–</td>
<td>–</td>
<td align="center">–</td>
</tr>
<tr>
<td>Hydén (1995)<sup><xref ref-type="bibr" rid="bibr13-0194599811432535">13</xref></sup></td>
<td>21</td>
<td>+</td>
<td>+</td>
<td>Same cohort</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0194599811432535">
<label>a</label>
<p>Standardization of diagnostic workup (+: diagnostic workup was the same for all included patients; –: diagnostic workup differed between patients); Selection bias: selection of patients does not influence outcome (+: the chance of diagnosing neuroborreliosis was not influenced by patient characteristics, disease characteristics, or earlier test outcomes; –: serology results influenced the selection of patients for CSF analysis; CSF was not examined in seronegative patients); completeness of data (+: the percentage of missing data does not exceed 20%; –: the percentage of missing data exceeds 20%); same cohort: the patients in this study are part of the larger cohort in the more recent publication from the same author.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Hydén et al<sup><xref ref-type="bibr" rid="bibr11-0194599811432535">11</xref></sup> included 62 adult patients with sudden SHL in a 10-year period. Blood and CSF samples were taken on admission. Seven patients (12%) had either IgG or IgM antibodies against <italic>Borrelia</italic> in their serum. CSF testing as reference for diagnosing neuroborreliosis showed no abnormalities in the seropositive patients. Since no intrathecal antibodies against <italic>Borrelia</italic> were found in the seronegative patients, neuroborreliosis was ruled out in all patients.</p>
<p>Finizia et al<sup><xref ref-type="bibr" rid="bibr9-0194599811432535">9</xref></sup> performed a prospective study on 19 adult patients with sudden hearing loss. Six patients (32%) had IgG or IgM antibodies against <italic>Borrelia</italic> in their serum. Ten patients, of whom 4 were seropositive, had either or both elevated protein content and pleiocytosis in the CSF, suggesting some kind of pathology in the central nervous system. However, none of the patients had intrathecal antibodies against <italic>Borrelia</italic>, while other causes of CSF abnormalities were not reported. Therefore, the criteria for definite neuroborreliosis were not fulfilled in any of the patients. The prevalence of serum antibodies against <italic>Borrelia</italic> is very high in this patient group, compared with 13.5% reported in a study of the general population,<sup><xref ref-type="bibr" rid="bibr18-0194599811432535">18</xref></sup> which was cited by the authors.</p>
<p>The data from these 2 studies were pooled in a 2 × 2 table (<xref ref-type="table" rid="table4-0194599811432535"><bold>Table 4</bold></xref>), resulting in 81 patients with sudden SHL. Of these patients, 16% had positive serology for <italic>Borrelia</italic>, which is similar to the general population in the south of Sweden. The prevalence of neuroborreliosis in this patient group was 0%, as none of the patients was diagnosed with neuroborreliosis.</p>
<table-wrap id="table4-0194599811432535" position="float">
<label>Table 4.</label>
<caption>
<p>Pooled Data of Finizia et al<sup><xref ref-type="bibr" rid="bibr9-0194599811432535">9</xref></sup> and Hydén et al<sup><xref ref-type="bibr" rid="bibr11-0194599811432535">11</xref></sup></p>
</caption>
<graphic alternate-form-of="table4-0194599811432535" xlink:href="10.1177_0194599811432535-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Neuroborreliosis +</th>
<th align="center">Neuroborreliosis –</th>
<th align="center">Total</th>
<th align="center">Predictive Value</th>
<th align="center">95% CI<sup><xref ref-type="table-fn" rid="table-fn4-0194599811432535">a</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td>ELISA +</td>
<td>0</td>
<td>13</td>
<td>13</td>
<td>0.00</td>
<td>0.00; 0.25</td>
</tr>
<tr>
<td>ELISA –</td>
<td>0</td>
<td>68</td>
<td>68</td>
<td>1.00</td>
<td>0.95; 1.00</td>
</tr>
<tr>
<td>Total</td>
<td>0</td>
<td>81</td>
<td>81</td>
<td>81</td>
<td>81</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0194599811432535">
<label>a</label>
<p>Confidence intervals were calculated using binomial exact confidence interval calculation according to Clopper and Pearson,<sup><xref ref-type="bibr" rid="bibr19-0194599811432535">19</xref></sup> using <ext-link ext-link-type="uri" xlink:href="http://statpages.org/confint.html">http://statpages.org/confint.html</ext-link>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Based on these data, the positive predictive value of ELISA for neuroborreliosis in patients with sudden SHL is 0%, whereas the negative predictive value is 100%.</p>
</sec>
<sec id="section4-0194599811432535">
<title>Translating Evidence into Practice</title>
<p>This article shows that there is no evidence to support the added value of serological testing for <italic>Borrelia</italic> for diagnosing neuroborreliosis in patients with sudden sensorineural hearing loss. Despite positive serology of 16%, the prevalence of neuroborreliosis in the available best studies is zero.</p>
<p>The major strength of this evidence-based case report is that we were able to study neuroborreliosis in both seropositive and seronegative patients, thus providing the ability to assess the specificity of ELISA for diagnosing neuroborreliosis.</p>
<p>Some aspects need further consideration. First, both studies were performed in the south of Sweden, where the prevalence of <italic>Borrelia</italic>-infected ticks is high. We have added the data of the 2 × 2 tables from the 2 studies. Still, the number of patients is relatively small. Compared with other countries, this may have resulted in an overestimation of the prevalence of positive serology.</p>
<p>Second, since antibody titers in serum and CSF take some time to develop, a patient infected with <italic>Borrelia</italic> may show negative results at the first presentation. Therefore, it has been recommended to test seronegative patients with symptoms suggestive of Lyme disease again after a few weeks. The patients in both studies were tested once. Therefore, the diagnosis may have been missed, leading to an underestimation of the prevalence of <italic>Borrelia-</italic>directed antibodies in both serum and CSF.</p>
<p>Third, if patients presenting with sudden SHL do not remember a tick bite or erythema migrans, this does neither rule out positive serology testing nor a diagnosis of neuroborreliosis. But in considering the diagnosis of neuroborreliosis, it should be noted that solitary loss of function in one nerve is very rare. In addition, our data suggest that routine screening for <italic>Borrelia</italic>-directed antibodies in these patients is not worthwhile.</p>
<p>Finally, if patients report a tick bite or other unexplained symptoms beside sudden SHL, neuroborreliosis should be considered and serological testing is justified. However, even with positive serology, neuroborreliosis is rarely reported in patients with sudden SHL.</p>
</sec>
<sec id="section5-0194599811432535">
<title>Answer to Our Patient</title>
<p>We conclude that there is no evidence regarding the added value of routine diagnostic serologic testing for <italic>Borrelia</italic> in diagnosing neuroborreliosis in patients with sudden SHL. Moreover, the diagnostic value of determining <italic>Borrelia</italic>-directed antibodies for diagnosing (ie, ruling in or ruling out) neuroborreliosis in patients with sudden SHL has as yet not been demonstrated in valid clinical scientific studies.</p>
<p>Therefore, we consider it very unlikely that routine diagnostic serologic testing for <italic>Borrelia</italic> has additive value in diagnosing neuroborreliosis in patients with sudden SHL.</p>
<p>We informed our patient in the clinical case about our above conclusions. Because she remembers neither a tick bite nor erythema migrans, although other neurological symptoms have been ruled out, we refrained from testing her serum for antibodies against <italic>Borrelia</italic>.</p>
<p>We informed her that many patients with sudden SHL have some degree of recovery within a few weeks, even though a reason for the sudden hearing loss is rarely found, and there is considerable debate about the effectiveness of corticosteroid therapy. We planned a follow-up consultation a few weeks later to review her complaints and reassess her hearing.</p>
</sec>
<sec id="section6-0194599811432535">
<title>Author Contributions</title>
<p><bold>Renée Bakker</bold>, Acquisition of data, analysis and interpretation of data, construction of the search strategy, selection of relevant articles, validation of articles, formulation of figures and tables, writing of article design, revising the article critically for important content, final approval of the version to be published; <bold>Mark C. J. Aarts</bold>, formulating clinical question, acquisition of data, analysis and interpretation of data, construction of the search strategy, selection of relevant articles, validation of articles, formulation of figures and tables, writing of article design, revising the article critically for important content, final approval of the version to be published; <bold>Geert J. M. G. van der Heijden</bold>, construction of the search strategy, analysis of data, adjusting of figures and tables, writing of article design, revision of the article, revising the article critically for important content, final approval of the version to be published; <bold>Maroeska M. Rovers</bold>, formulating clinical question, construction of the search strategy, validation of articles, analysis of data, adjusting of figures and tables, writing of article design, revision of the article, revising the article critically for important content, final approval of the version to be published.</p>
</sec>
<sec id="section7-0194599811432535">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599811432535">
<label>1.</label>
<citation citation-type="journal">
<collab>Dutch Association for Otorhinolaryngology and Head and Neck Surgery</collab>. <article-title>Position paper: idiopathic sudden sensorineural hearing loss</article-title>. <source>Ned Tijdschr KNO-Heelk</source>. <year>2001</year>;<volume>7</volume>:<fpage>127</fpage>-<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr2-0194599811432535">
<label>2.</label>
<citation citation-type="web">
<collab>CBO Quality Institute for Healthcare</collab>. <article-title>Guideline Lyme borreliosis</article-title>. <year>2004</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.cbo.nl/Downloads/264/lymebor2004.pdf">http://www.cbo.nl/Downloads/264/lymebor2004.pdf</ext-link></comment>. <access-date>Accessed August 13, 2010</access-date>.</citation>
</ref>
<ref id="bibr3-0194599811432535">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schreiber</surname><given-names>BE</given-names></name>
<name><surname>Agrup</surname><given-names>C</given-names></name>
<name><surname>Haskard</surname><given-names>DO</given-names></name>
<name><surname>Luxon</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Sudden sensorineural hearing loss</article-title>. <source>Lancet</source>. <year>2010</year>;<volume>375</volume>:<fpage>1203</fpage>-<lpage>1211</lpage>.</citation>
</ref>
<ref id="bibr4-0194599811432535">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>G</given-names></name>
<name><surname>Van Dam</surname><given-names>AP</given-names></name>
<name><surname>Schwartz</surname><given-names>I</given-names></name>
<name><surname>Dankert</surname><given-names>J</given-names></name>
</person-group>. <article-title>Molecular typing of <italic>Borrelia burgdorferi sensu lato</italic>: taxonomic, epidemiological, and clinical implications</article-title>. <source>Clin Microbiol Rev</source>. <year>1999</year>;<volume>12</volume>:<fpage>633</fpage>-<lpage>653</lpage>.</citation>
</ref>
<ref id="bibr5-0194599811432535">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mygland</surname><given-names>A</given-names></name>
<name><surname>Ljostad</surname><given-names>U</given-names></name>
<name><surname>Fingerle</surname><given-names>V</given-names></name>
<name><surname>Rupprecht</surname><given-names>T</given-names></name>
<name><surname>Schmutzhard</surname><given-names>E</given-names></name>
<name><surname>Steiner</surname><given-names>I</given-names></name>
</person-group>. <article-title>EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis</article-title>. <source>Eur J Neurol</source>. <year>2010</year>;<volume>17</volume>:<fpage>8</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr6-0194599811432535">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorenzi</surname><given-names>MC</given-names></name>
<name><surname>Bittar</surname><given-names>RS</given-names></name>
<name><surname>Pedalini</surname><given-names>ME</given-names></name>
<name><surname>Zerati</surname><given-names>F</given-names></name>
<name><surname>Yoshinari</surname><given-names>NH</given-names></name>
<name><surname>Bento</surname><given-names>RF</given-names></name>
</person-group>. <article-title>Sudden deafness and Lyme disease</article-title>. <source>Laryngoscope</source>. <year>2003</year>;<volume>113</volume>:<fpage>312</fpage>-<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr7-0194599811432535">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walther</surname><given-names>LE</given-names></name>
<name><surname>Hentschel</surname><given-names>H</given-names></name>
<name><surname>Oehme</surname><given-names>A</given-names></name>
<name><surname>Gudziol</surname><given-names>H</given-names></name>
<name><surname>Beleites</surname><given-names>E</given-names></name>
</person-group>. <article-title>Lyme disease—a reason for sudden sensorineural hearing loss and vestibular neuronitis?</article-title> <source>Laryngootologie</source>. <year>2003</year>;<volume>82</volume>:<fpage>249</fpage>-<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr8-0194599811432535">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gagnebin</surname><given-names>J</given-names></name>
<name><surname>Maire</surname><given-names>R</given-names></name>
</person-group>. <article-title>Infection screening in sudden and progressive idiopathic sensorineural hearing loss: a retrospective study of 182 cases</article-title>. <source>Otol Neurol</source>. <year>2002</year>;<volume>23</volume>:<fpage>160</fpage>-<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr9-0194599811432535">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Finizia</surname><given-names>C</given-names></name>
<name><surname>Jonsson</surname><given-names>R</given-names></name>
<name><surname>Hanner</surname><given-names>P</given-names></name>
</person-group>. <article-title>Serum and cerebrospinal fluid pathology in patients with sudden sensorineural hearing loss</article-title>. <source>Acta Otolaryngol</source>. <year>2001</year>;<volume>121</volume>:<fpage>823</fpage>-<lpage>830</lpage>.</citation>
</ref>
<ref id="bibr10-0194599811432535">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gagnebin</surname><given-names>J</given-names></name>
<name><surname>Maire</surname><given-names>R</given-names></name>
</person-group>. <article-title>Advantage of screening for infection in sudden and progressive hearing loss</article-title>. <source>Schweiz Med Wochenschr</source>. <year>2000</year>;(<issue>suppl 125</issue>):<fpage>89S</fpage>-<lpage>91S</lpage>.</citation>
</ref>
<ref id="bibr11-0194599811432535">
<label>11.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Hydén</surname><given-names>D</given-names></name>
<name><surname>Roberg</surname><given-names>M</given-names></name>
</person-group>. <article-title>Is <italic>Borrelia</italic> antibody testing motivated in the routine investigation of patients with acute audio- (and/or) vestibular loss?</article-title> In: <person-group person-group-type="editor">
<name><surname>Claussen</surname><given-names>CF</given-names></name>
<name><surname>Haid</surname><given-names>CT</given-names></name>
<name><surname>Hofferberth</surname><given-names>B</given-names></name>
</person-group> eds. <article-title>Equilibrium Research, Clinical Equilibriometry and Modern Treatment: XXth regular meeting of the Bárány Society 1998</article-title>. <source>Int Congress Series</source>. <year>2000</year>;<volume>1201</volume>:<fpage>429</fpage>-<lpage>433</lpage>.</citation>
</ref>
<ref id="bibr12-0194599811432535">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peltomaa</surname><given-names>M</given-names></name>
<name><surname>Pyykko</surname><given-names>I</given-names></name>
<name><surname>Sappala</surname><given-names>I</given-names></name>
<name><surname>Viitanen</surname><given-names>L</given-names></name>
<name><surname>Viljanen</surname><given-names>M</given-names></name>
</person-group>. <article-title>Lyme borreliosis, an etiological factor in sensorineural hearing loss?</article-title> <source>Eur Arch Otolaryngol</source>. <year>2000</year>;<volume>257</volume>:<fpage>317</fpage>-<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr13-0194599811432535">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hydén</surname><given-names>D</given-names></name>
<name><surname>Roberg</surname><given-names>M</given-names></name>
<name><surname>Odkvist</surname><given-names>L</given-names></name>
</person-group>. <article-title>Borreliosis as a cause of sudden deafness and vestibular neuritis in Sweden</article-title>. <source>Acta Otolaryngol Suppl</source>. <year>1995</year>;<volume>520</volume>:<fpage>320</fpage>-<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr14-0194599811432535">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richardson</surname><given-names>H</given-names></name>
<name><surname>Birchall</surname><given-names>JP</given-names></name>
<name><surname>Hill</surname><given-names>J</given-names></name>
<name><surname>McMaster</surname><given-names>T</given-names></name>
</person-group>. <article-title>Should we routinely screen for Lyme disease in patients with asymmetrical hearing loss?</article-title> <source>Br J Audiol</source>. <year>1994</year>;<volume>28</volume>:<fpage>59</fpage>-<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr15-0194599811432535">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riechelmann</surname><given-names>H</given-names></name>
<name><surname>Hauser</surname><given-names>R</given-names></name>
<name><surname>Vogt</surname><given-names>A</given-names></name>
<name><surname>Mann</surname><given-names>W</given-names></name>
</person-group>. <article-title>The <italic>Borrelia</italic> titer in ENT diseases</article-title>. <source>Laryngorhinootologie</source>. <year>1990</year>;<volume>69</volume>:<fpage>65</fpage>-<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr16-0194599811432535">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wissen-Siegert</surname><given-names>I</given-names></name>
<name><surname>Welkoborsky</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Value and status of neurologic, serologic, internal medicine and orthopedic studies in routine diagnosis of sudden deafness</article-title>. <source>Laryngorhinootologie</source>. <year>1990</year>;<volume>69</volume>:<fpage>140</fpage>-<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr17-0194599811432535">
<label>17.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Hanner</surname><given-names>P</given-names></name>
<name><surname>Rosenhall</surname><given-names>U</given-names></name>
<name><surname>Edstrom</surname><given-names>S</given-names></name>
<name><surname>Kaijser</surname><given-names>B</given-names></name>
</person-group>. <article-title>Hearing impairment in patients with antibody production against <italic>Borrelia burgdorferi</italic> antigen</article-title>. <source>Lancet</source>. <year>1989</year>;<volume>1</volume>(<issue>8628</issue>):<fpage>13</fpage>-<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr18-0194599811432535">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dumler</surname><given-names>JS</given-names></name>
<name><surname>Dotevall</surname><given-names>L</given-names></name>
<name><surname>Gustafson</surname><given-names>R</given-names></name>
<name><surname>Granström</surname><given-names>M</given-names></name>
</person-group>. <article-title>A population-based seroepidemologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden</article-title>. <source>J Infect Dis</source>. <year>1997</year>;<volume>75</volume>:<fpage>720</fpage>-<lpage>722</lpage>.</citation>
</ref>
<ref id="bibr19-0194599811432535">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clopper</surname><given-names>CJ</given-names></name>
<name><surname>Pearson</surname><given-names>ES</given-names></name>
</person-group>. <article-title>The use of confidence or fiducial limits illustrated in the case of the binomial</article-title>. <source>Biometrika</source>. <year>1934</year>:<volume>26</volume>:<fpage>404</fpage>-<lpage>413</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>